Expanding the malaria antibody toolkit: development and characterisation of Plasmodium falciparum RH5, CyRPA, and CSP recombinant human monoclonal antibodies
Malaria, an infection caused by apicomplexan parasites of the genus Plasmodium, continues to exact a significant toll on public health with over 200 million cases world-wide, and annual deaths in excess of 600,000. Considerable progress has been made to reduce malaria burden in endemic countries in...
Main Authors: | Nacer, A, Kivi, G, Pert, R, Juronen, E, Holenya, P, Aliprandini, E, Amino, R, Silvie, O, Quinkert, D, Le Duff, Y, Hurley, M, Reimer, U, Tover, A, Draper, SJ, Gilbert, S, Ho, MM, Bowyer, PW |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Frontiers Media
2022
|
Similar Items
-
Expanding the Malaria Antibody Toolkit: Development and Characterisation of Plasmodium falciparum RH5, CyRPA, and CSP Recombinant Human Monoclonal Antibodies
by: Adéla Nacer, et al.
Published: (2022-06-01) -
Structural basis for inhibition of erythrocyte invasion by antibodies to Plasmodium falciparum protein CyRPA
by: Lin Chen, et al.
Published: (2017-02-01) -
The RH5-CyRPA-Ripr complex as a malaria vaccine target
by: Ragotte, RJ, et al.
Published: (2020) -
Structure of the malaria vaccine candidate antigen CyRPA and its complex with a parasite invasion inhibitory antibody
by: Paola Favuzza, et al.
Published: (2017-02-01) -
Divergent roles for the RH5 complex components, CyRPA and RIPR in human-infective malaria parasites
by: Knuepfer, E, et al.
Published: (2019)